Screener
Indivior Pharmaceuticals, Inc. INDV Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | $1,341 | $1,300 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' deficit | ||
| Common stock, par value $0.001 per share (2026) and $0.50 per share (2025). Issued shares: 122 (2026) and 125 (2025) | — | 62 |
| Additional paid-in capital | 165 | 112 |
| Accumulated other comprehensive loss | (29) | (30) |
| Accumulated deficit | (280) | (243) |
| Total stockholders' deficit | (144) | (98) |
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s common stock, par value (in dollars per share)?
- Indivior Pharmaceuticals, Inc. (INDV) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s common stock, par value (in dollars per share) decreased by 99.8% year-over-year, from $0.5 to $0.
Ask your AI about Indivior Pharmaceuticals, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude